Middle East and Africa Cancer Therapeutics Market Outlook (2021-2031)
The Middle East and Africa Cancer Therapeutics Market size was valued at US$ 4,503.08 Mn in 2024 and is projected to reach US$ 9,078.95 Mn by 2031, growing at a CAGR of 10.6% during 2025 - 2031.
Report Coverage
- Therapy Type: Chemotherapy, Targeted Therapy, Radiation Therapy, Hormone Therapy, Other Therapy Types
- Indications: Blood Cancer, Lung Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Cervical Cancer, Liver & Intrahepatic Bile Duct Cancer, Thyroid Cancer, Other Indications
- Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Channel
US$ 4,503.08 Mn
Market size in 2024
US$ 9,078.95 Mn
Market Size by 2031
10.6%
CAGR, 2025 - 2031
2025-2031
Forecast Period
1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Middle East and Africa Cancer Therapeutics Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Middle East and Africa Cancer Therapeutics Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Middle East and Africa Cancer Therapeutics Market Regional Analysis
6.2 Middle East and Africa Cancer Therapeutics Market Revenue 2021-2031 (US$ Million)
6.3 Middle East and Africa Cancer Therapeutics Market Forecast Analysis
7. Middle East and Africa Cancer Therapeutics Market Analysis – by Therapy Type
7.1 Chemotherapy
- 7.1.1 Overview
- 7.1.2 Chemotherapy: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Targeted Therapy
- 7.2.1 Overview
- 7.2.2 Targeted Therapy: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Radiation Therapy
- 7.3.1 Overview
- 7.3.2 Radiation Therapy: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Hormone Therapy
- 7.4.1 Overview
- 7.4.2 Hormone Therapy: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
7.5 Other Therapy Types
- 7.5.1 Overview
- 7.5.2 Other Therapy Types: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8. Middle East and Africa Cancer Therapeutics Market Analysis – by Indications
8.1 Blood Cancer
- 8.1.1 Overview
- 8.1.2 Blood Cancer: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Lung Cancer
- 8.2.1 Overview
- 8.2.2 Lung Cancer: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Breast Cancer
- 8.3.1 Overview
- 8.3.2 Breast Cancer: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Colorectal Cancer
- 8.4.1 Overview
- 8.4.2 Colorectal Cancer: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Prostate Cancer
- 8.5.1 Overview
- 8.5.2 Prostate Cancer: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Stomach Cancer
- 8.6.1 Overview
- 8.6.2 Stomach Cancer: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.7 Cervical Cancer
- 8.7.1 Overview
- 8.7.2 Cervical Cancer: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.8 Liver & Intrahepatic Bile Duct Cancer
- 8.8.1 Overview
- 8.8.2 Liver & Intrahepatic Bile Duct Cancer: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.9 Thyroid Cancer
- 8.9.1 Overview
- 8.9.2 Thyroid Cancer: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
8.10 Other Indications
- 8.10.1 Overview
- 8.10.2 Other Indications: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
9. Middle East and Africa Cancer Therapeutics Market Analysis – by Distribution Channel
9.1 Hospital Pharmacies
- 9.1.1 Overview
- 9.1.2 Hospital Pharmacies: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Retail Pharmacies
- 9.2.1 Overview
- 9.2.2 Retail Pharmacies: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Online Channel
- 9.3.1 Overview
- 9.3.2 Online Channel: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast, 2021-2031 (US$ Million)
10. Middle East and Africa Cancer Therapeutics Market – Middle East and Africa Analysis
10.1 Overview
10.2 Middle East and Africa- 10.2.1 Middle East and Africa Cancer Therapeutics Market Breakdown, by Key Country, 2025 and 2031 (%)
- 10.2.1.1 Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast Analysis – by Country
- 10.2.1.1 UAE: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.1.1 UAE: Middle East and Africa Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.1.2 UAE: Middle East and Africa Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.1.3 UAE: Middle East and Africa Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.2 Saudi Arabia: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.2.1 Saudi Arabia: Middle East and Africa Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.2.2 Saudi Arabia: Middle East and Africa Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.2.3 Saudi Arabia: Middle East and Africa Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.3 Turkey: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.3.1 Turkey: Middle East and Africa Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.3.2 Turkey: Middle East and Africa Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.3.3 Turkey: Middle East and Africa Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.4 Qatar: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.4.1 Qatar: Middle East and Africa Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.4.2 Qatar: Middle East and Africa Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.4.3 Qatar: Middle East and Africa Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.5 Kuwait: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.5.1 Kuwait: Middle East and Africa Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.5.2 Kuwait: Middle East and Africa Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.5.3 Kuwait: Middle East and Africa Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.6 South Africa: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.6.1 South Africa: Middle East and Africa Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.6.2 South Africa: Middle East and Africa Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.6.3 South Africa: Middle East and Africa Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.7 Bahrain: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.7.1 Bahrain: Middle East and Africa Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.7.2 Bahrain: Middle East and Africa Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.7.3 Bahrain: Middle East and Africa Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.8 Oman: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.8.1 Oman: Middle East and Africa Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.8.2 Oman: Middle East and Africa Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.8.3 Oman: Middle East and Africa Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.9 Egypt: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.9.1 Egypt: Middle East and Africa Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.9.2 Egypt: Middle East and Africa Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.9.3 Egypt: Middle East and Africa Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.10 Nigeria: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.10.1 Nigeria: Middle East and Africa Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.10.2 Nigeria: Middle East and Africa Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.10.3 Nigeria: Middle East and Africa Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.11 Algeria: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.11.1 Algeria: Middle East and Africa Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.11.2 Algeria: Middle East and Africa Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.11.3 Algeria: Middle East and Africa Cancer Therapeutics Market Breakdown, by Distribution Channel
- 10.2.1.12 and Rest of MEA: Middle East and Africa Cancer Therapeutics Market – Revenue and Forecast to 2031 (US$ Million)
- 10.2.1.12.1 and Rest of MEA: Middle East and Africa Cancer Therapeutics Market Breakdown, by Therapy Type
- 10.2.1.12.2 and Rest of MEA: Middle East and Africa Cancer Therapeutics Market Breakdown, by Indications
- 10.2.1.12.3 and Rest of MEA: Middle East and Africa Cancer Therapeutics Market Breakdown, by Distribution Channel
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 Astellas Pharma Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Eli Lilly and Co
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Novartis AG
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 Merck KGaA
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 AstraZeneca
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Pfizer Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Hoffmann-La Roche Ltd
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Johnson & Johnson
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 AbbVie Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
13.10 Bristol-Myers Squibb Co
- 13.10.1 Key Facts
- 13.10.2 Business Description
- 13.10.3 Products and Services
- 13.10.4 Financial Overview
- 13.10.5 SWOT Analysis
- 13.10.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations
Access the Full M Market Report
Get segment-level forecasts, regional estimates, competitive benchmarking, company profiles and downloadable Excel datasets.
